Pharmafile Logo
Pharmafocus logo
Advanced Search
laboratory-testing-az

BioVersys receives €20 Million EU Financing to develop new antibiotics

April 14, 2021
Research and Development EU

The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company, have today announced the signing of a €20 …

News
AstraZeneca sign

AstraZeneca’s Farxiga falls short in Phase III trials for treatment of COVID-19

April 13, 2021
Manufacturing and Production AstraZeneca, COVID-19, covid-19 treatment, farxiga, pharma, pharma news

AstraZeneca’s Farxiga drug, usually used in patients with diabetes, did not show statistical significance in the Phase III trial into …

News

Regeneron’s drug cocktail shown to prevent symptomatic COVID-19

April 13, 2021
Manufacturing and Production COVID-19, REGEN-COV, Regeneron, covid-19 treatment, pharma, pharma news

Regeneron’s REGEN-COV treatment cocktail for COVID-19, a combination between casirivimab and imdevimab, has shown a significant reduction in progression to …

News
pexels-lucy-6816451_cropped

Asthma drug Budesonide helps COVID-19 recovery at home

April 13, 2021
Manufacturing and Production COVID-19, asthma drug

Budesonide, a widely-used asthma drug, is the first treatment to be proven to speed up the recovery of COVID-19 patients …

News

BC Platforms partners with Australian Tissue Bank to improve breast cancer treatment

April 13, 2021
Manufacturing and Production Cancer, data

BC Platforms have announced a data partnership with the Australian Breast Cancer Tissue Bank (ABCTB) for its BCRQUEST.com Global Data …

News

Akari Therapeutics open IND with FDA for bullous pemphigoid treatment

April 13, 2021
Manufacturing and Production FDA

Akari Therapeutics have opened an investigational new drug application (IND) with the FDA for its multicentre Phase III study with …

News

Sanofi to invest €400 million on Singapore vaccine production site

April 12, 2021
Sales and Marketing Sanofi, Vaccine

Sanofi have today announced a €400 million investment to create a unique vaccine production centre in Singapore, in partnership with …

News

EMA launch investigation into J&J’s COVID-19 vaccine amid US blood clot reports

April 12, 2021
Sales and Marketing COVID-19, EMA, J&J, JJ, Vaccine

The EMA is reviewing reports of rare blood clots in four people in the US who received Johnson & Johnson’s …

News

Immutep achieves FDA Fast Track designation for soluble LAG-3 protein

April 12, 2021
Sales and Marketing FDA, HNSCC

Immutep, a biotechnology company developing novel immunotherapy treatments for cancer, infectious disease, and autoimmune disease, has achieved FDA Fast Track …

News

Gynaecologic cancer research collaboration announced

April 12, 2021
Sales and Marketing clinical oncology

Context Therapeutics and Integral Molecular have announced a research collaboration and licensing agreement for the development of an anti-claudin 6 …

News

Immunotherapy combination presented at AACR meeting shows promise in brain cancers

April 12, 2021
Sales and Marketing Cancer Conferences | Cancer Conferences 2020 | Oncology Conferences | Oncology Conferences 2020 | International Cancer Conference

Researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust have found that immunotherapy together with …

News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 9, 2021
Medical Communications covid 19 news, covid-19 news, news, news roundup, pharma, pharma news

A number of new COVID-19 developments have emerged in April already: AstraZeneca has halted the trial of its COVID-19 vaccine …

News

Exscientia enter first-ever AI cancer drug into Phase I trials

April 9, 2021
Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news

Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …

News
moderna_norwood_plant

Moderna publishes antibody persistence data of COVID-19 vaccine

April 9, 2021
Medical Communications

Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in …

News
lilly_entrance_web

Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint

April 9, 2021
Medical Communications COVID-19, Eli Lily

Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did …

News
abbottweb

Abbott receives CE mark approval for TriClip device

April 9, 2021
Medical Communications

Abbott have received CE Mark approval for its next-generation TriClip Transcatheter Tricuspid Valve Repair System, the first-of-its-kind tricuspid heart valve …

News

Novartis MS therapy gains MHRA and EC approval

April 8, 2021
European Commission, MHRA, Novartis, pharma, pharma news

The MHRA and European Commission have both granted marketing authorisation to Novartis for its Kesimpta therapy, for the treatment of …

News
Gilead sign

FDA approve Gilead’s breast cancer treatment after Phase III trial

April 8, 2021
FDA, Gilead, Trodelvy, pharma, pharma news

The FDA has approved Gilead’s Trodelvy therapy for the treatment of metastatic triple-negative breast cancer (TNBC).

News
img_4190-e1376666350337-web

MHRA recommends AstraZeneca jab not be offered to under 30s

April 8, 2021

The MHRA have recommended that people under the age of 30 not be offered the AstraZeneca COVID-19 vaccine, due to …

News

GBT publish successful results from sickle cell disease study

April 8, 2021

Global Blood Therapeutics (GBT) have published the successful results from their Phase III study of Oxbryta (voxelotor) tablets in patients …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025